Arbutus Biopharma Corporation
NASDAQ:ABUSBiotechnology
Healthcare
$4.07 +1.13%
+$0.05 today
- Market cap
- $623.90M
- Beta
- 0.63
- P/E (TTM)
- 5.4
- EPS (TTM)
- $0.83
52W Low $3.04High $5.10
Volume 2.44M
Average 1.76M
Private 5-step workspace
Build a ABUS investment thesis
Turn Arbutus Biopharma Corporation research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.